Intrinsic Value of S&P & Nasdaq Contact Us

PMV Pharmaceuticals, Inc. PMVP NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
57/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$18.00
+1124.5%

Stock Statistics — PMVP

PMV Pharmaceuticals, Inc. (PMVP) has a market capitalization of $78.39M and trades at $1.47. The 52-week range is 0.81-1.88.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1, Earnings Per Share (EPS) of $-1.48.

The stock has a beta of 1.40, operates in the Healthcare sector.

Trading Data
Current Price$1.47
52-Week Range0.81-1.88
Volume1.29M
Avg Volume (30D)627.83K
Market Cap$78.39M
Beta (1Y)1.40
Company
IPO Date2020-09-25
Employees47
CEODavid H. Mack
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS69353Y1038
CUSIP69353Y103
Income (Latest Year)
Gross Profit$-133K
EBITDA$-86.21M
Operating Income$-86.21M
Net Income$-77.74M
EPS$-1.48
EPS Diluted$-1.48
Shares Outstanding$52.54M
Balance Sheet (Latest Year)
Total Assets$116.56M
Current Assets$115.23M
Cash & ST Investments$112.94M
Total Liabilities$11.85M
Total Debt$838K
Net Debt$-37.15M
Total Equity$104.71M
Debt / Equity0.01
Valuation Ratios
P/E Ratio-1
P/B Ratio0.75
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message